N-acetylserotonin

Identification

Generic Name
N-acetylserotonin
DrugBank Accession Number
DB04275
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 218.2518
Monoisotopic: 218.105527702
Chemical Formula
C12H14N2O2
Synonyms
  • N-(2-(5-Hydroxy-1H-indol-3-yl)ethyl)acetamide
  • N-acetyl serotonin
  • N-Acetyl-5-hydroxytryptamine

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug events
Improve clinical decision support with information oncontraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Target Actions Organism
USepiapterin reductase Not Available Humans
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including:blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity

Not Available

Pathways
Pathway Category
Tryptophan Metabolism Metabolic
Pharmacogenomic Effects/ADRsBrowse all" title="" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
Not Available

的相互作用

Drug InteractionsLearn More" title="" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Chemical TaxonomyProvided byClassyfire
Description
This compound belongs to the class of organic compounds known as hydroxyindoles. These are organic compounds containing an indole moiety that carries a hydroxyl group.
Kingdom
Organic compounds
Super Class
Organoheterocyclic compounds
Class
Indoles and derivatives
Sub Class
Hydroxyindoles
Direct Parent
Hydroxyindoles
Alternative Parents
3-alkylindoles/1-hydroxy-2-unsubstituted benzenoids/Substituted pyrroles/Heteroaromatic compounds/Propargyl-type 1,3-dipolar organic compounds/Carboximidic acids/Azacyclic compounds/Organopnictogen compounds/Organooxygen compounds/Organonitrogen compounds
show 1 more
1-hydroxy-2-unsubstituted benzenoid/3-alkylindole/Aromatic heteropolycyclic compound/Azacycle/Benzenoid/Carboximidic acid/Carboximidic acid derivative/Heteroaromatic compound/Hydrocarbon derivative/Hydroxyindole
show 10 more
Molecular Framework
Aromatic heteropolycyclic compounds
External Descriptors
acetamides, hydroxyindoles (CHEBI:17697)/a small molecule (N-ACETYL-SEROTONIN)
Affected organisms
Not Available

Chemical Identifiers

UNII
P4TO3C82WV
CAS number
1210-83-9
InChI Key
MVAWJSIDNICKHF-UHFFFAOYSA-N
InChI
InChI = 1 s / C12H14N2O2 c1-8 (15) 13-5-4-9 -7-14-12-3-2-10(16)6-11(9)12/h2-3,6-7,14,16H,4-5H2,1H3,(H,13,15)
IUPAC Name
N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]acetamide
SMILES
CC(=O)NCCC1=CNC2=C1C=C(O)C=C2

References

一般引用
Not Available
Human Metabolome Database
HMDB0001238
KEGG Compound
C00978
PubChem Compound
903
PubChem Substance
46507511
ChemSpider
879
BindingDB
29612
ChEBI
17697
ChEMBL
CHEMBL33103
ZINC
ZINC000000066104
PharmGKB
PA140222717
PDBe Ligand
ASE
Wikipedia
N-Acetylserotonin
PDB Entries
1nas/4a6e/6tr6

Clinical Trials

Clinical TrialsLearn More" title="" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
Phase Status Purpose Conditions Count

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
Property Value Source
Water Solubility 0.569 mg/mL ALOGPS
logP 0.98 ALOGPS
logP 1 Chemaxon
logS -2.6 ALOGPS
pKa (Strongest Acidic) 9.56 Chemaxon
pKa (Strongest Basic) -1.6 Chemaxon
Physiological Charge 0 Chemaxon
Hydrogen Acceptor Count 2 Chemaxon
Hydrogen Donor Count 3 Chemaxon
Polar Surface Area 65.12 Å2 Chemaxon
Rotatable Bond Count 3 Chemaxon
Refractivity 61.8 m3·mol-1 Chemaxon
Polarizability 23.59 Å3 Chemaxon
Number of Rings 2 Chemaxon
Bioavailability 1 Chemaxon
Rule of Five Yes Chemaxon
Ghose Filter Yes Chemaxon
Veber's Rule No Chemaxon
MDDR-like规则 No Chemaxon
Predicted ADMET Features
Property Value Probability
Human Intestinal Absorption + 1.0
Blood Brain Barrier + 0.9861
Caco-2 permeable - 0.5836
P-glycoprotein substrate 底物 0.6014
P-glycoprotein inhibitor I Non-inhibitor 0.9881
P-glycoprotein inhibitor II Non-inhibitor 0.7464
Renal organic cation transporter Non-inhibitor 0.6181
CYP450 2C9 substrate Non-substrate 0.7433
CYP450 2D6 substrate Non-substrate 0.542
CYP450 3A4 substrate 底物 0.5187
CYP450 1A2 substrate Inhibitor 0.9107
CYP450 2C9 inhibitor Non-inhibitor 0.907
CYP450 2D6 inhibitor Non-inhibitor 0.5849
CYP450 2C19 inhibitor Non-inhibitor 0.9025
CYP450 3A4 inhibitor Non-inhibitor 0.7286
CYP450 inhibitory promiscuity High CYP Inhibitory Promiscuity 0.5678
Ames test Non AMES toxic 0.9165
Carcinogenicity Non-carcinogens 0.9437
Biodegradation Not ready biodegradable 0.7943
Rat acute toxicity 1.8664 LD50, mol/kg Not applicable
hERG inhibition (predictor I) Weak inhibitor 0.9582
hERG inhibition (predictor II) Non-inhibitor 0.7027
ADMET data is predicted usingadmetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
Spectrum Spectrum Type Splash Key
GC-MS Spectrum - GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) GC-MS splash10-0f6x-0692000000-96e09fa6d98b96bcf1e4
GC-MS Spectrum - GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) GC-MS splash10-0fsm-0950000000-1bfd0dec31c3cbabefdd
GC-MS Spectrum - GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) GC-MS splash10-0udl-0495000000-4408ea40213cdc89bf39
GC-MS Spectrum - GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) GC-MS splash10-0159-0690000000-15c09141663fccc3546f
GC-MS Spectrum - GC-MS (3 TMS) GC-MS splash10-0f6x-1592000000-742cca756ead51503626
GC-MS Spectrum - GC-MS (2 TMS) GC-MS splash10-0f6x-2695000000-c377bb4d833e7c3880da
Predicted GC-MS Spectrum - GC-MS Predicted GC-MS Not Available
GC-MS Spectrum - GC-MS GC-MS splash10-0f6x-1592000000-742cca756ead51503626
GC-MS Spectrum - GC-MS GC-MS splash10-0f6x-2695000000-c377bb4d833e7c3880da
GC-MS Spectrum - GC-EI-TOF GC-MS splash10-0f6x-0692000000-60b556c70b30588d69f4
GC-MS Spectrum - GC-EI-TOF GC-MS splash10-0f6x-0595000000-687eb11cf30796ac9321
GC-MS Spectrum - GC-EI-TOF GC-MS splash10-0159-0590000000-3fa8283c51c6d0bcbb54
MS/MS Spectrum - Quattro_QQQ 10V, Positive LC-MS/MS splash10-03di-0920000000-9c0d187c13aabfa510d9
MS/MS Spectrum - Quattro_QQQ 25V, Positive LC-MS/MS splash10-03di-0900000000-025ebd6d665bfe7141d3
MS/MS Spectrum - Quattro_QQQ 40V, Positive LC-MS/MS splash10-014i-1900000000-cdac2a24252af2ce8c65
Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available
Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available
Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available
Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available
Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available
Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available
LC-MS/MS Spectrum - LC-ESI-qTof , Positive LC-MS/MS Not Available
MS/MS Spectrum - , negative LC-MS/MS splash10-0aor-3890000000-f3ae8731ba8f76a62c23
MS/MS Spectrum - , positive LC-MS/MS splash10-03yi-2900000000-4fc1ad68abd1d2588527
MS/MS Spectrum - , positive LC-MS/MS splash10-03di-0900000000-73493993faa05c0e2d48
1H NMR Spectrum 1D NMR Not Applicable
[1H,13C] 2D NMR Spectrum 2D NMR Not Applicable

Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets tounlock new
insights and accelerate drug research.
Learn more
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
Learn more
Kind
Protein
Organism
Humans
Pharmacological action
Unknown
General Function
Sepiapterin reductase activity
Specific Function
Catalyzes the final one or two reductions in tetra-hydrobiopterin biosynthesis to form 5,6,7,8-tetrahydrobiopterin.
Gene Name
SPR
Uniprot ID
P35270
Uniprot Name
Sepiapterin reductase
分子量
28048.13 Da
References
  1. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]

Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52